014 is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
014 has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Advanced Solid Tumor, Advanced Parkinson's Disease.
Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd., UCB Pharma.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
014 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
014 has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Advanced Parkinson's Disease.
014 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.